Governance Licensing Pharmaceutical Industry 
Bill of Health
MAY 5, 2023
To solve this tension, the Commission recognizes that patent law already offers a solution: compulsory licensing. The Proposal A compulsory license allows third parties to use a patent without asking prior permission from the owner of said patent. The powers to grant such a license will be in the hands of the Commission.
Bill of Health
AUGUST 29, 2022
government funding, announced that it felt “a special obligation … to use our resources to bring this pandemic to an end as quickly as possible.” These pledges can take a variety of forms and have been made for decades in industries ranging from automotive (e.g., After the pandemic, it is willing to offer paid licenses.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bill of Health
JULY 11, 2024
Between 2017 and 2021, the Peruvian, Chilean, Guatemalan, Uruguayan, Mexican, and Argentinian governments awarded the purchase of such medicines to single suppliers without a public tender or in favor of companies with bad corporate practices. The industry gave more than $14.2
HIT Consultant
JANUARY 9, 2025
While proprietary systems like SAS require hefty licensing fees, open-source tools are, of course, free. These examples highlight a pivotal shift: with robust validation and governance frameworks in place, open-source tools can achieve the reliability and compliance required to meet regulatory standards.
Healthcare IT Today
JANUARY 23, 2024
global lead of the Accenture Life Sciences business, said, “Through our investment in QuantHealth, we are further solidifying our commitment to utilizing advanced technologies to bring revolutionary change in the pharmaceutical industry. Petra Jantzer, Ph.D., Terms of the investment were not disclosed.
Bill of Health
SEPTEMBER 28, 2023
Such a provision could prevent the public from paying twice for publicly-funded medical products—first through their taxes subsidizing government funded research and development, and second to procure the product in an inflated U.S. pharmaceutical market. Moreover, the NASDAQ Biotechnology Index increased by 374% from 1995 to 2000.
Verisys
JULY 13, 2023
The onus of ensuring these CROs have proper controls in place often falls on the shoulders of the pharmaceutical company and can be challenging to monitor. Medication Samples Supplying medication samples to prescriber’s offices is common in the pharmaceutical industry, especially with launch brands.
Expert insights. Personalized for you.
291 
Let's personalize your content